We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
GSK urged the agency to “either refrain from taking action to alter Zofran’s pregnancy-related labeling or take action to alter the labeling” and explain which data warranted the labeling changes. Read More
The EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended five new drugs and two generics for EU approval at its November meeting and called for restrictions on two others. Read More
In a win for Mallinckrodt, the Patent Trial and Appeal Board (PTAB) invalidated BioVie’s patent on a treatment for ascites — an accumulation of abdominal fluid often linked to advanced liver cirrhosis. Read More
President Trump announced his intention to nominate Hahn as the agency’s leadership role on Nov. 1, and the nomination was officially sent to the Senate. Read More
An FDA advisory committee voted unanimously on Thursday to recommend approval of Amarin Pharmaceuticals’ Vascepa (icosapent ethyl) to reduce the risk of cardiovascular events in adults. Read More